How Biotechs Use Bayesian Statistics to Design Smarter Clinical Trials

Episode 53 of Biotech Business with Fexingo dives into the world of Bayesian adaptive clinical trials — a statistical approach that lets biotechs learn from data mid-study and potentially cut trial costs by 30%. Lucas and Luna explore how startups like Berry Consultants and Cytel are helping drug developers reduce patient numbers while increasing the chance of hitting endpoints. They unpack a real case: how a mid-stage Parkinson's trial used Bayesian modeling to stop early for futility, saving $40 million. The episode also touches on regulators' growing comfort with Bayesian methods, especially in rare disease trials where patient pools are tiny. No algorithm hype — just a clear look at how smarter math is changing drug development timelines. #Biotech #ClinicalTrials #BayesianStatistics #AdaptiveTrials #DrugDevelopment #Startups #BerryConsultants #Cytel #ParkinsonsDisease #RareDisease #FDA #StatisticalDesign #Business #Technology #FexingoBusiness #BusinessPodcast #LifeSciences #Podcast Keep every episode free: buymeacoffee.com/fexingo